NCT00563823View on ClinicalTrials.gov

Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2010

Conditions
Melanoma (Skin)
Interventions
DRUG

vatalanib

Trial Locations (2)

CB2 2QQ

Addenbrooke's Hospital, Cambridge

LE1 5WW

Leicester Royal Infirmary, Leicester

All Listed Sponsors
lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT00563823 - Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery | Biotech Hunter | Biotech Hunter